Opioid Dispensing Device for Post-Operative Pain in Cancer Patients

Launched by COLUMBIA UNIVERSITY · Oct 14, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new device called Addinex, which is designed to safely store and dispense opioid medications for pain relief after surgery. Specifically, the study is focused on helping cancer patients who are going to have major surgery and will need pain management afterward. By comparing the Addinex device to traditional pill bottles, researchers want to learn how patients feel about using this new method for managing their medication.

To be eligible for this trial, participants must be adults aged 18 and older, scheduled for major surgery related to cancer, and expected to receive opioids for pain relief after the procedure. They should be comfortable using technology, as the study involves a mobile app and some questionnaires. Participants will share their experiences with the Addinex device and will have a phone interview about a month after they stop using it. This research could help determine if the Addinex device is a better option for managing pain after surgery in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (age greater than or equal to 18 years)
• • Planned for major cancer-related surgery and expected to receive a postoperative opioid prescription
• • Must speak English or Spanish
• • Must have access to a smartphone or an alternative smart device (e.g., iPhone, Android phone, iPad, Surface, etc.).
• • Co-enrollment in trials involving pharmacologic therapy is allowed
• Exclusion Criteria:
• • Patients who are taking opioids daily prior to the surgical procedure
• • Patients unable to physically utilize the device
• • Patients unable to self-administer medications
• • Patients uncomfortable with using iPhone or iPad-based technology